Global Med Technologies to Report Second Quarter Financial Results on Tuesday, August 12, 2008
August 05 2008 - 9:00AM
PR Newswire (US)
Conference Call to Follow Release DENVER, Aug. 5
/PRNewswire-FirstCall/ -- Global Med Technologies(R), Inc. ("Global
Med" or the "Company") (OTC:GLOB) (BULLETIN BOARD: GLOB) , an
international e-Health, medical information technology company,
will report its second quarter financial results on Tuesday, August
12, 2008, after the market closes. The Company will host a
conference call at 4:30 p.m. EDT on the same day. (Logo:
http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO)
Conference Call Details: Dr. Mick Ruxin, Chief Executive Officer,
Tom Marcinek, President and Chief Operating Officer, and Darren
Craig, Vice President of Finance, will discuss the second quarter
financial results and will be available to answer questions. The
one-hour conference call will be held on Tuesday, August 12, 2008,
at 4:30 p.m. EDT. Interested parties are welcome to call the
telephone numbers listed below five minutes prior to the start of
the conference call. Callers within the U.S. should call:
1-866-789-9224. Callers that are outside of the U.S. should call:
1-706-679-9621. Callers should reference "Global Med Second Quarter
Financial Results" to the conference call operator. The conference
call ID number will be: 58996634. An automated replay of the
conference call will be available from August 12, 2008 at 5:30 p.m.
EDT until August 14, 2008 at 11:59 p.m. EDT. To access the replay,
callers within the U.S. should call: 1-800-642-1687. Callers
outside of the U.S. should call: 1-706-645-9291 and enter Global
Med's access code of 58996634. The replay of the conference call
will be available from August 14, 2008 onward at Global Med's
website at http://www.globalmedtech.com/. About Global Med
Technologies, Inc. Global Med Technologies(R), Inc. is an
international medical software company which develops regulated and
non-regulated software products and services for the healthcare
industry. As a leading provider of blood and laboratory software
applications and services, Global Med's products are deployed in 20
countries and serve over 1,400 transfusion centers, blood banks and
laboratories. Global Med's U.S. division, Wyndgate Technologies(R),
provides Vein-to-Vein(R) tracking through its Donor Doc(TM),
SafeTrace(R), SafeTrace Tx(R) and ElDorado Donor(TM) software
products. Each year, Wyndgate's products and services manage more
than eight million blood components, representing over 27% of the
U.S. blood supply. Global Med's European subsidiary, Inlog, SA, is
a leading provider of donor center and transfusion management
systems as well as cellular therapy software, laboratory
information systems and quality assurance medical software systems
internationally. Inlog's products include EdgeBlood**, EdgeTrack**,
EdgeCell, EdgeLab and SAPA. Global Med's U.S. division, eDonor(R),
provides a web-based donor relationship management system that
integrates recruitment, scheduling, retention and fulfillment for
national as well as local community blood centers and hospitals.
eDonor's products and services are designed to complement Global
Med's strong line of international blood management and laboratory
information software and service solutions. Global Med's U.S.
subsidiary, PeopleMed(R), Inc., provides cost-effective customized
software validation, consulting and compliance solutions to
hospitals and donor centers. For more information about Global
Med's products and services, please call 800-996-3428 or visit
http://www.globalmedtech.com/, http://www.peoplemed.com/,
http://www.inlog.com/ and http://www.wyndgate.com/. **FDA 510(k)
clearance required prior to sales in the U.S. This news release may
include statements that constitute forward-looking statements,
usually containing the words "believe," "estimate," "project,"
"expects" or similar expressions. These statements are made
pursuant to the safe harbor provisions of the Private Securities
Litigation Reform Act of 1995. Forward-looking statements
inherently involve risks and uncertainties that could cause actual
results to differ materially from the forward-looking statements.
By making these forward-looking statements, the Company undertakes
no obligation to update these statements for revisions or changes
after the date of this news release. Company Contact: Investor
Contact: Global Med Technologies, Inc. portfolio pr Michael I.
Ruxin, M.D. Paul Holm, President (303) 238-2000 (212) 888-4570
http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO
http://photoarchive.ap.org/ DATASOURCE: Global Med Technologies,
Inc. CONTACT: Company Contact, Michael I. Ruxin, M.D. of Global Med
Technologies, Inc., +1-303-238-2000, ; or Investor Contact, Paul
Holm, President of portfolio pr, +1-212-888-4570, , for Global Med
Technologies, Inc. Web site: http://www.globalmedtech.com/
Copyright